Tech Company Financing Transactions
Arbovax Funding Round
Arbovax closed a $1.7 million financing round on 4/4/2014. Backers included private investors.
Transaction Overview
Company Name
Announced On
4/4/2014
Transaction Type
Venture Equity
Amount
$1,694,917
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
617 Hutton St. 101
Raleigh, NC 27606
USA
Raleigh, NC 27606
USA
Phone
Website
Email Address
Overview
Biotechnology company working on vaccines against insect-borne viral diseases like Dengue fever.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Chris English
Chief Executive Officer
Malcolm Thomas
Browse more venture capital transactions:
Prev: 4/3/2014: P2 Science venture capital transaction
Next: 4/4/2014: Imgur venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs